Gefitinib for recurrent non-small-cell lung cancer: all things are not created equal

J Clin Oncol. 2008 Sep 10;26(26):4233-5. doi: 10.1200/JCO.2008.17.0837.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Clinical Trials as Topic
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Gefitinib